Cambridge Investment Research Advisors’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-9,770	Closed	-$363K	–	2740
2020 Q3	$363K	Buy	9,770 +5,385	+123%	+$200K	﹤0.01%	1806
2020 Q2	$225K	Buy	+4,385	New	+$225K	﹤0.01%	2101
2020 Q1	–	Sell	-3,366	Closed	-$201K	–	2323
2019 Q4	$201K	Buy	+3,366	New	+$201K	﹤0.01%	2208